Volume 8, Issue 4 (10-2020)                   J. Pediatr. Rev 2020, 8(4): 237-246 | Back to browse issues page


XML Print


1- Department of Dermatology, Faculty of Medicine, Mazandaran University of Medical Science, Sari, Iran.
2- Department of Health, Faculty of Health Sciences, Mazandaran University of Medical Science, Sari, Iran.
3- Department of Dermatology, Faculty of Medicine, Mazandaran University of Medical Science, Sari, Iran. , zhajheydari@yahoo.com
Abstract:   (4000 Views)
Context: Warts are benign cutaneous and mucosal growths caused by human papillomavirus. Warts are the most common skin diseases seen by pediatric dermatologists. Warts are often self-limited, especially in children, but some lesions are not resolved despite repeated treatments and referred to as recalcitrant warts. 
Evidence acquisition: Electronic databases such as Google Scholar, PubMed, and Scopus were searched during 2000-2018 and a review was conducted for articles published in English on pediatric warts by focusing on recalcitrant warts.
Results: If warts are asymptomatic and being in a location that causes no cosmetic or other problems, observation is the ideal management course. Most parents and children prefer treatment for their warts. There are three modalities of treatment: medical, surgical, and immunotherapy.
Conclusions: Treatment of warts is a therapeutic challenge that depends on the patient’s age and the type of warts. Despite treatment according to evidence-based guidelines, a significant proportion of warts are failed to respond. This condition is an unsolved problem in practice. The management for treating these lesions has remained unclear and a wide range of the second line of treatments has been developed.
Full-Text [PDF 472 kb]   (2813 Downloads) |   |   Full-Text (HTML)  (3239 Views)  
Type of Study: Narrative Review | Subject: Dermatology
Received: 2019/08/10 | Accepted: 2019/12/7 | Published: 2020/10/1

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.